SCHEDULE: Wellington Management Discloses 7.6% Stake in Inspire Medical

Wellington Management Group LLP and its affiliates have reported a 7.6% beneficial ownership stake in Inspire Medical Systems, Inc. as of December 31, 2025.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, has filed a Schedule 13G.
• The group beneficially owns an aggregate of 2,211,091 shares of Inspire Medical Systems, Inc. common stock.
• This represents 7.6% of the class of securities.
• The reporting persons hold shared voting power over 1,934,784 shares and shared dispositive power over 2,211,091 shares.
• The shares are held on behalf of clients of Wellington Investment Advisers, with no single client known to hold more than 5% individually.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral disclosure. A Schedule 13G filing is a routine regulatory requirement for passive investors and does not inherently convey positive or negative sentiment about the issuer's performance or prospects.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes, indicating a major asset manager's position in a company. Wellington Management's stake in Inspire Medical Systems, a medical technology company, suggests continued institutional interest in the healthcare sector, particularly in innovative device companies.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, potentially signaling confidence from a major asset manager.
• Company Management: Awareness of a large, passive institutional holder, which can influence long-term strategic considerations.

Key Dates

Keywords

Inspire Medical Systems, Wellington Management, Schedule 13G, Beneficial Ownership, Common Stock, Medical Devices, Healthcare, Institutional Investor